SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The $ROSIE project centers around a unique, AI-powered memecoin inspired by "Rosie the Robot," a beloved character known for her role as a caring, motherly robot in popular culture. The purpose of $ROSIE is twofold: entertainment through an interactive AI feature and social impact via charitable donations.  Users can interact with an AI version of Rosie on the project’s website, where they can ask questions and engage in conversations. The utility of $ROSIE goes beyond typical memecoins by enabling users to donate tokens, which will be directed towards charitable causes supporting mothers. Through this initiative, the project combines the viral appeal of meme tokens with meaningful contributions to social causes, while leveraging AI technology to create a novel user experience.

Rosie the Robot

ROSIE CRYPTO is gaining attention, particularly regarding its integration with Phantom Wallet. The community highlights the token's 'early moon' potential and strong momentum, suggesting a possible breakout. Bullish sentiment is building, with many emphasizing it as an opportune entry point.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending due to an FDA investigation into allergic reactions linked to specific lots of its and Grifols' immune globulin products, raising concerns about potential voluntary recalls and revenue impact. The community is discussing the extent of the issue, comparing it to a previous recall, and speculating on possible short-selling manipulation. Despite the concerns, some investors express confidence in the company's fundamentals and long-term growth potential, viewing the dip as a buying opportunity.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending due to renewed interest in its low float and potential for a short squeeze, with some traders drawing comparisons to other high-flying stocks. Community chatter highlights the company's potential crypto treasury and anticipation for news catalysts. Some are wary of the stock's history of volatility and advising caution.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the crypto community discusses its recent price movements and potential catalysts, including the ongoing government shutdown and anticipation of XRP ETFs.  Community members are debating entry points, long-term potential, and whether XRP can break through resistance levels.  Broader discussions include Ripple's partnerships and the potential impact of regulatory clarity on the crypto's future.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals ($SNDX) is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community debating the likelihood of approval and its potential impact. Some traders point to the drug's existing approval for a related condition and analysts' price targets while others cite concerns about side effects and market manipulation. Discussions also mention potential competition and buyout scenarios.

An AI x Metaverse Protocol that is building the future of virtual interactions.

Virtual Protocol

Virtual Protocol is trending due to recent listing news and a surge in interest surrounding its AI agent ecosystem. Community members are actively discussing its potential, the utility of its agents, and possible price targets. The broader context includes the growing excitement around AI-related crypto projects and Base network tokens.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

Picard Medical (PMI) is trending due to recent stock volatility, leading the company to release a statement clarifying they are unaware of any undisclosed material changes. The community is actively discussing potential Monday catalysts, dilution concerns, and whether the stock presents a buying opportunity or a trap. Bullish sentiment revolves around the company's exclusive artificial heart technology and potential for a v-shape recovery.

Sailana Inu, the sister of legendary Saitama Inu, is bringing back the Wolfpack and OG community vibes that previously sent Saitama to a $7 billion marketcap in 2021. The power of community mixed with great leadership is what will take this project to great heights. Join the movement, join the pack, become apart of the Sailana Army . Together, we will create something that will go down in history, and something that will be talked about years from now.

Sailana Inu

Sailana Inu is trending as its community rallies around the project, anticipating a significant breakout. The community, known as the Wolfpack, expresses strong conviction and emphasizes holding for long-term gains. Discussions highlight the project's potential and a belief that a substantial upward movement is on the horizon.

PAW Chain has launched the world’s first Layer 3-centric blockchain, enhancing scalability and inter-chain operability across networks. The roadmap features a decentralized exchange, merchant services, and a DAO, all optimized for high-volume, low-cost transactions. Leveraging smart contracts and EVM compatibility, PAW Chain is set to transform digital finance by providing secure, efficient solutions, allowing any project to go multi-chain, underscored by a community-driven governance model and rigorous security standards including regular security audits.

$PAW is trending amidst community excitement surrounding its multi-chain ecosystem and ongoing development, including news about new projects launching and validator updates. Community members express bullish sentiment, focusing on the project's potential for growth and interoperability. Discussions also highlight staking and upcoming partnerships.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as the community speculates on the impact of recent news and exchange listings. Community members are actively discussing price predictions and potential catalysts for growth, drawing comparisons to other meme coins. The listing and broader discussions around meme coins are driving interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EXPE or MELI: Which Is the Better Value Stock Right Now?

EXPE vs. MELI: Which Stock Is the Better Value Option?

Should Value Investors Buy Expedia Group (EXPE) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Why Expedia (EXPE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Expedia Group Appoints Rob Bevegni as Vice President of Investor Relations

Expedia Group (NASDAQ: EXPE) announced the appointment of Rob Bevegni as Vice President of Investor Relations. Rob joins the companys Global Finance Leadership Team and will lead Expedia Groups...

UNPACK '26: EXPEDIA, HOTELS.COM, AND VRBO REVEAL HOW TRAVELERS WILL EXPLORE THE WORLD IN 2026

UNPACK '26: EXPEDIA, HOTELS.COM, AND VRBO REVEAL HOW TRAVELERS WILL EXPLORE THE WORLD IN 2026 UNPACK '26: EXPEDIA, HOTELS.COM, AND VRBO REVEAL HOW TRAVELERS WILL EXPLORE THE WORLD IN 2026 PR Newswire...

Here's Why Expedia (EXPE) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Expedia Group (EXPE) shares climbed 5.5% on Tuesday, after several analysts lifted their price targets based on the online travel company's strong earnings report last week.Citi raised its price target to $206 from $177, while Susquehanna raised the target to $200 from $175. Both research firms kept their 'neutral' ratings on the stock, according to reports on The Fly.Bernstein raised its price target to $210 from $162, although it believes further share upside from current levels would be hard to come by in the near term. To be sure, analysts' price targets are typically for the forward 12-month period.Expedia on Thursday <a href="https://stocktwits.com/news-articles/markets/equity/expedia-stock-pops-on-outlook-boost-as-business-travel-rebounds-but-ceo-says-lower-end-of-market-in-wait-and-see-mode/chrVUztRd3p">reported</a> stronger-than-expected second-quarter results and raised its full-year revenue growth forecast, citing robust business travel and an early recovery in the U.S. market. Shares gained 4% on Friday, as analysts penciled in favorable travel trends that were recently echoed by Booking Holdings (BKNG) and Airbnb (ABNB).On Stocktwits, retail sentiment has remained firmly in the "extremely bullish" zone since last Friday, as of the latest reading. However, message volume dropped 38% in the previous 24 hours, and some users warned of a pullback in shares.<figure class="image"><img style="aspect-ratio:640/68;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_13_at_9_40_30_AM_png_7a7bd8809c.webp" alt="Screenshot 2025-08-13 at 9.40.30 AM.png" width="640" height="68"><figcaption>EXPE sentiment and message volume as of August 12 | Source: Stocktwits</figcaption></figure>"Set trailing stops to exit at very slight profit. Best wishes, everyone," said a user.<stembedurl>https://stocktwits.com/AutoAZTrader/message/624783020</stembedurl>Currently, 21 of the 36 analysts covering the stock rate it 'hold,' 14 rate it 'buy' and one rates it 'strong sell,' according to Koyfin data. Their average price target is $221.12, which implies a nearly 9% upside from EXPE's last close.<a href="https://stocktwits.com/symbol/EXPE">Expedia shares</a> are up 9% year-to-date, just a notch lower than the 9.6% gains in the benchmark S&amp;P 500 (SPX) index.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/rumble-on-sparks-retail-frenzy-as-stock-surges-60-after-rebranding-improving-financials/chrzUKlRdJz">RumbleOn Sparks Retail Frenzy As Stock Surges 60% After Rebranding, Improving Financials</a>

In this photo illustration an Expedia logo seen displayed on a smartphone. (Photo Illustration by Mateusz Slodkowski/SOPA Images/LightRocket via Getty Images)

Expedia Gets Price-Target Hikes After Strong Q2, Outlook Raise: Retail Extremely Bullish

Shares of the online travel company rose 5.5% on Monday, higher than the 4% gains on Friday following its quarterly report.

Equity

Shares of the online travel company rose 5.5% on Monday, higher than the 4% gains on Friday following its quarterly report.


Consumer stocks rose last week, with discretionary shares&nbsp;outperforming staples as investors&nbsp;positioned themselves ahead of Tuesday's inflation report.The Consumer Discretionary Select Sector SPDR Fund (XLY) rose 3.6%, nearly recovering losses from the week prior. The Consumer Staples Select Sector SPDR Fund (XLP) rose 2.9%, its biggest weekly gain since October 2023.Here are the top gainers in the sector:&nbsp;Expedia Group (weekly gain 9.7%)A major part of the lift came on Friday, after the online travel company's quarterly report. Expedia&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/expedia-stock-pops-on-outlook-boost-as-business-travel-rebounds-but-ceo-says-lower-end-of-market-in-wait-and-see-mode/chrVUztRd3p">beat expectations</a> for revenue and profit for its second quarter, and the company raised its annual outlook for revenue and gross booking growth.Following the report, Bernstein raised its price target on the stock by a wide margin, from $162 to $215, noting the strength in the company's business travel segment.&nbsp;Monster Beverage (weekly gain 9.6%)The energy drink was also the beneficiary of an end-of-the-week rally. Shares gained 6.4% on Friday after reporting higher-than-expected quarterly revenue and profit.The energy drinks segment has garnered particular investor interest lately; CEO Hilton Schlosberg&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/monster-beverages-stock-heads-for-best-day-in-over-2-years-after-upbeat-q2-retail-traders-turn-extremely-bullish/chrnEfXRdE0">noted</a> that energy drinks are being purchased by an increasing number of households, with per capita consumption also on the rise.&nbsp;Tyson Foods (weekly gain 8.6%)The meat producer is on a winning streak, with shares rising for six consecutive sessions. Tyson Foods, on Monday, beat quarterly revenue and profit expectations, and raised its sales growth forecast. It now stands at 2% to 3%, compared to its previous estimate of 1%, driven partly by the strength in pork and chicken meat sales. For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/target-faces-growth-challenges-as-staff-give-thumbs-down-to-management-efforts-report/chruFqaRdIR">Target Faces Growth Challenges As Staff Give Thumbs Down To Management Efforts: Report</a>

People shop at a grocery store in Brooklyn on July 11, 2024 in New York City. (Photo by Spencer Platt/Getty Images)

Expedia, Monster Beverage, Tyson Foods: Strong Earnings Drive Best In Sector Gains Last Week

Discretionary stocks outpaced staples last week, as investors positioned themselves ahead of Tuesday's inflation report.

Expedia Q2 Earnings & Revenues Beat Estimates, Q3 Guidance Raised

EXPE posts strong Q2 results with double-digit B2B growth, and boosts the Q3 and 2025 outlook for bookings, revenues and margins.

Expedia Group, Inc. is an online travel company, which engages in the provision of travel products and services to leisure and corporate travelers. It operates through the following segments: B2C, B2B, and Trivago. The B2C segment offers a full range of travel and advertising services to worldwide customers through a variety of consumer brands. The B2B segment refers to a wide range of travel and non-travel companies including airlines, offline travel agents, online retailers, corporate travel management, and financial institutions. The Trivago segment generates advertising revenue primarily from sending referrals to online travel companies and travel service providers from hotel metasearch websites. The company was founded in 1994 and is headquartered in Seattle, WA.

Expedia Group Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

EXPE
Expedia Group Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EXPE News

EXPEExpedia Group Inc